Ottawa – Health Canada has approved the first vaccine for respiratory syncytial virus (RSV) for adults age 60 and over. Manufacturer GSK says the federal agency has approved its new vaccine called Arexvy. Doctors have been calling for an RSV vaccine for seniors because although the virus is common, older people are much more likely to become severely ill and …
London – As reports of self-inflicted harm and suicidal thoughts have increased among those who use Ozempic or Wegovy in Europe and the United Kingdom, health regulators are looking at potential risk of adverse effects linked to these drugs. The European Medicines Agency said it was evaluating 150 such cases. These drugs are known to reduce blood sugar levels and …
NY – A drug called AOH1996, that kills cancer, has shown promise in eradicating solid tumors while sparing healthy cells. The pill targeting a cancerous form of the protein PCNA, has been developed over 20 years with the City of Hope, a leading cancer research and treatment organisation, developing it in the United States. Protein PCNA is crucial in DNA …
London – Soliris (eculizumab) has been approved in the European Union (EU) for expanded use to include the treatment of refractory generalised myasthenia gravis (gMG) in children and adolescents aged six to 17 years who are anti-acetylcholine receptor (AChR) antibody-positive (Ab+). This is the first and only targeted therapy approved for the treatment of paediatric patients with the disease in the EU. …
Singapore – Nasopharyngeal cancer (NPC) is a disease that develops from tissues in the nasopharynx, the passageway behind the nose that connects to the respiratory system and the ear. It predominantly affects Chinese individuals, particularly those of southern Chinese heritage, and is more prevalent in males aged 30 to 60. According to Dr Donovan Eu, a consultant in Otolaryngology, “Nose …
The Canadian Skin of Colour & Diversity Scholarship program will provide funds for dermatology residents to implement their ideas on addressing care gaps among underrepresented Canadians. KIRKLAND– Together with the Skin Spectrum Summit, Pfizer Canada has announced the new Canadian Skin of Colour & Diversity Scholarship program to improve dermatological care for underrepresented populations, including those with deeper skin tones, …
Ottawa – On World Hepatitis Day, people in Canada and across the globe are raising awareness about viral hepatitis and embracing this year’s theme “We’re Not Waiting”, acknowledging the urgent need for testing and treatment for those living with viral hepatitis. Viral hepatitis is preventable, treatable and in many cases curable. However, viral hepatitis is one of the leading causes …
Ottawa – Through a longstanding partnership, the Canadian Institutes of Health Research (CIHR) and JDRF Canada support research to improve the prevention, screening, management, and treatment of diabetes in Canada. Together, CIHR and JDRF are providing $33M to support 12 diabetes research teams. The teams will focus their research on diverse aspects of diabetes care: four teams will work on …
London – AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in China as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2-low (IHC 1+ or IHC 2+/ISH-) breast cancer who have received a prior systemic therapy in the metastatic setting or developed disease recurrence during or within six months of completing adjuvant chemotherapy. Enhertu is a …
LA – Fountain Life, a health technology company, has developed an innovative artificial intelligence (AI) coronary artery scan that can detect heart conditions long before symptoms even develop. This procedure involves a quick CAT scan of the heart after injecting a simple dye into the vein. The AI technology then analyzes the scan results to provide valuable insights. This non-invasive …
